We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TCR2 Therapeutics

News List

TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity contractpharma
November 12, 2020
Strategic partnership will leverage technical capabilities at ElevateBio for the production of TC-210 to support Phase II clinical trial.
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing biospace
March 22, 2018
TCR2 Therapeutics Inc.,announced today the completion of an oversubscribed Series B financing of $125 million.
TCR2 Therapeutics Snags $125 Million To Expand T-Cell Program biospace
March 22, 2018
TCR2 Therapeutics snagged $125 million in an oversubscribed Series B financing round to advance two T-Cell receptor (TCR) programs through clinical proof-of-concept.